Few recontracted the virus after being cured, and some of those who got reinfected spontaneously cleared it.

A study found that young people treated with biologic drugs for inflammatory bowel disease or various rheumatologic conditions were at risk.

Melbourne and Amsterdam have a much better handle on hep C rates among injection drug users than Baltimore, San Francisco or Montreal.

The opioid epidemic is likely fueling the rise, which is particularly steep in Appalachia.

A major academic center found only two cases of on-the-job infections via cuts in a 13-year period.

In an analysis of the investigational treatment, cure rates were very high for those without cirrhosis after both 8 and 12 weeks of therapy.

In a small study, those with HCV who received HCV-infected kidneys who were then treated with Zepatier (grazoprevir/elbasvir) all did well.

This is particularly true among men older than 50, who warrant greater monitoring.

A major randomized, double-blind study pitted Livalo (pitavastatin) against Pravachol (pravastatin).

However, eight weeks of sofosbuvir/velpatasvir/voxilaprevir worked as well as 12 weeks of Epclusa for those with genotype 3 and cirrhosis.